6.
Shen X, Xie Y, Chen C, Wang X
. Effects of electroacupuncture on cognitive function in rats with Parkinson's disease. Int J Physiol Pathophysiol Pharmacol. 2016; 7(3):145-51.
PMC: 4697670.
View
7.
Guo J, Chen X, Wu M, Wang D, Zhao Y, Li Q
. Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial. Lancet. 2024; 404(10468):2187-2196.
DOI: 10.1016/S0140-6736(24)02261-X.
View
8.
Inoue K, Fujioka S, Nagaki K, Suenaga M, Kimura K, Yonekura Y
. Table tennis for patients with Parkinson's disease: A single-center, prospective pilot study. Clin Park Relat Disord. 2021; 4:100086.
PMC: 8299968.
DOI: 10.1016/j.prdoa.2020.100086.
View
9.
Yadav S, Rai S, Singh S
. Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. J Chem Neuroanat. 2016; 80:1-10.
DOI: 10.1016/j.jchemneu.2016.11.009.
View
10.
Li L, Wang Z, You Z, Huang J
. Prevalence and Influencing Factors of Depression in Patients with Parkinson's Disease. Alpha Psychiatry. 2024; 24(6):234-238.
PMC: 10837606.
DOI: 10.5152/alphapsychiatry.2023.231253.
View
11.
Armstrong M
. Advances in dementia with Lewy bodies. Ther Adv Neurol Disord. 2021; 14:17562864211057666.
PMC: 8613883.
DOI: 10.1177/17562864211057666.
View
12.
Olsson K, Franzen E, Johansson A
. A Pilot Study of the Feasibility and Effects of Table Tennis Training in Parkinson Disease. Arch Rehabil Res Clin Transl. 2021; 2(3):100064.
PMC: 7853352.
DOI: 10.1016/j.arrct.2020.100064.
View
13.
Kehagia A, Barker R, Robbins T
. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol. 2010; 9(12):1200-1213.
DOI: 10.1016/S1474-4422(10)70212-X.
View
14.
Bloem B, Okun M, Klein C
. Parkinson's disease. Lancet. 2021; 397(10291):2284-2303.
DOI: 10.1016/S0140-6736(21)00218-X.
View
15.
Chen Y, Tan C, Su H, Chien C, Sung P, Lin T
. Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson's disease with mild cognitive impairment. BJPsych Open. 2022; 8(6):e205.
PMC: 9707510.
DOI: 10.1192/bjo.2022.611.
View
16.
You Z, Wu Y, Wu R, Xu Z, Wu X, Wang X
. Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year. CNS Neurosci Ther. 2020; 26(9):972-980.
PMC: 7415202.
DOI: 10.1111/cns.13392.
View
17.
Rai S, Yadav S, Singh D, Singh S
. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat. 2015; 71:41-9.
DOI: 10.1016/j.jchemneu.2015.12.002.
View
18.
Zhang Y, Zhao J, Huang D, Chen W, Yuan C, Jin L
. Multiple comorbid sleep disorders adversely affect quality of life in Parkinson's disease patients. NPJ Parkinsons Dis. 2020; 6:25.
PMC: 7492275.
DOI: 10.1038/s41531-020-00126-x.
View
19.
Leroi I, Vatter S, Carter L, Smith S, Orgeta V, Poliakoff E
. Parkinson's-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trial. Ther Adv Neurol Disord. 2019; 12:1756286419852217.
PMC: 6611028.
DOI: 10.1177/1756286419852217.
View
20.
Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon E, Schlossmacher M
. Canadian guideline for Parkinson disease. CMAJ. 2019; 191(36):E989-E1004.
PMC: 6733687.
DOI: 10.1503/cmaj.181504.
View